Forbes India 30 Under 30 2023

You Can't Own my Genes

Published: Jun 29, 2013 06:28:16 AM IST
Updated: Jun 27, 2013 04:36:34 PM IST
You Can't Own my Genes

Our genes belong to us, not to some company that has patented them. The US Supreme Court recently gave this judgment in a case involving Myriad Genetics that had patented the two genes involved in familial breast cancer. This is good news for health care consumers, even in India where genetic tests are not yet common. The ruling allows small companies to use genetic tests for wellness and drug responses, says Anu Acharya, CEO, MapMyGenome, a genomics company in Hyderabad. While the volume of cancer tests involving Myriad’s patent are small here, there are tests for which firms have not been reporting results that involve other gene patents. The concern that this may have a negative effect on therapeutic innovation is misplaced. The court has ruled that any modification in the naturally-occurring gene is patented. This is a win for all—patients, researchers and biomedical companies.  

Check out our Festive offers upto Rs.1000/- off website prices on subscriptions + Gift card worth Rs 500/- from Click here to know more.

(This story appears in the 12 July, 2013 issue of Forbes India. To visit our Archives, click here.)

Post Your Comment
Required, will not be published
All comments are moderated